Skip to main content
OpenTrials

Clinical trial condition

Resectable Pancreatic Cancer

Explore clinical trials studying Resectable Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Resectable Pancreatic Cancer trial results

Completed

EUS vs. MDCT in Pancreatic Malignancy

NCT02115022

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Research Center in Gastroenterogy and Hepatology Craiova, Dolj, Romania
  • University Military Hospital Bucharest, Romania
  • Gastroenterology Department, Clinical Hospital Colentina Bucharest, Romania
  • Fundeni Clinical Institute Bucharest, Romania
View Trial Details
Completed

Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer

NCT01298011

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • TGen Clinical Research Services at Scottsdale Healthcare Scottsdale, Arizona, United States
  • St Mary's / Trinity Health Care Grand Rapids, Michigan, United States
  • Virginia Piper Cancer Institute Minneapolis, Minnesota, United States
  • University of Pittsburg Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

NCT04472910

Conditions
Resectable Pancreatic Cancer
Locations
  • BC Cancer Agency Vancouver Vancouver, British Columbia, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Ottawa Hospital Ottawa, Ontario, Canada
View Trial Details

Related conditions